Response-Guided Therapy as an Effective Strategy on Peginterferon Alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 2 and a High Viral Road

MLA

Yuichi Yamazaki, et al. “Response-Guided Therapy as an Effective Strategy on Peginterferon Alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 2 and a High Viral Road.” Gastroenterology, vol. 140, May 2011, p. S-911. EBSCOhost, https://doi.org/10.1016/s0016-5085(11)63781-5.

APA

Yuichi Yamazaki, Masatomo Mori, Hitoshi Takagi, Ken Sato, Norio Horiguchi, Satoru Kakizaki, & Hiroaki Hashizume. (2011). Response-Guided Therapy as an Effective Strategy on Peginterferon Alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 2 and a High Viral Road. Gastroenterology, 140, S-911. https://doi.org/10.1016/s0016-5085(11)63781-5

Chicago

Yuichi Yamazaki, Masatomo Mori, Hitoshi Takagi, Ken Sato, Norio Horiguchi, Satoru Kakizaki, and Hiroaki Hashizume. 2011. “Response-Guided Therapy as an Effective Strategy on Peginterferon Alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 2 and a High Viral Road.” Gastroenterology 140 (May): S-911. doi:10.1016/s0016-5085(11)63781-5.